Growth Arrest in Focal Dermal Hypoplasia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02463656|
Recruitment Status : Completed
First Posted : June 4, 2015
Last Update Posted : June 18, 2018
|Condition or disease|
|Focal Dermal Hypoplasia|
|Study Type :||Observational|
|Actual Enrollment :||16 participants|
|Official Title:||Growth Arrest in Focal Dermal Hypoplasia|
|Actual Study Start Date :||July 15, 2015|
|Actual Primary Completion Date :||March 30, 2016|
|Actual Study Completion Date :||May 31, 2018|
- Determination of Growth Hormone Deficiency [ Time Frame: 1 day ]Glucagon growth hormone stimulation test
- Determination of poor growth [ Time Frame: 1 day ]Bone age x-rays will be read independently and compared to the accepted standards and quantified as a standard deviation from chronological age.
- Determination of poor weight gain [ Time Frame: 1 day ]Evaluation of IGF-1 levels which are frequently low in children who are underweight or poorly nourished.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02463656
|Principal Investigator:||Stephanie C Hsu, MD||University of Colorado, Denver|